PHP
Parkman Healthcare Partners’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,697
| Closed | -$4.8M | – | 94 |
|
|
2024
Q1 | $4.8M | Buy |
+17,697
| New | +$4.8M | 0.59% | 56 |
|
|
2023
Q4 | – | Sell |
-44,160
| Closed | -$8.65M | – | 93 |
|
|
2023
Q3 | $8.65M | Buy |
+44,160
| New | +$8.65M | 1.59% | 18 |
|
|
2022
Q2 | – | Sell |
-10,000
| Closed | -$2.84M | – | 81 |
|
|
2022
Q1 | $2.84M | Sell |
10,000
-15,901
| -61% | -$4.52M | 0.83% | 41 |
|
|
2021
Q4 | $9.76M | Buy |
25,901
+901
| +4% | +$339K | 2.15% | 17 |
|
|
2021
Q3 | $10.3M | Sell |
25,000
-27,245
| -52% | -$11.2M | 2.61% | 9 |
|
|
2021
Q2 | $19.3M | Buy |
52,245
+2,245
| +4% | +$830K | 4.22% | 3 |
|
|
2021
Q1 | $14.5M | Buy |
50,000
+10,334
| +26% | +$3M | 3.36% | 3 |
|
|
2020
Q4 | $9.91M | Sell |
39,666
-339
| -0.8% | -$84.7K | 2.54% | 10 |
|
|
2020
Q3 | $9.06M | Buy |
40,005
+5
| +0% | +$1.13K | 2.4% | 10 |
|
|
2020
Q2 | $6.97M | Buy |
+40,000
| New | +$6.97M | 1.96% | 18 |
|